TSXV:RHT.H - Post by User
Comment by
lscfaon Dec 01, 2020 11:03am
223 Views
Post# 32009277
RE:The Bull Thesis
RE:The Bull Thesis Share dilution has increased the level of revenues required to justify share price.
| Annual revenue | 6,000,000 | 12,000,000 | 18,000,000 |
| 75% Gross margin | 4,500,000 | 9,000,000 | 13,500,000 |
| overhead | (8,000,000) | (8,000,000) | (8,000,000) |
| ebit | (3,500,000) | 1,000,000 | 5,500,000 |
| 30% tax | | (300,000) | (1,650,000) |
| Net income | (3,500,000) | 700,000 | 3,850,000 |
| Shs diluted | 179,830,977 | 179,830,977 | 179,830,977 |
| eps | ($0.019) | $0.004 | $0.021 |
| P/e | 20 | 20 | 20 |
| Sh value | ($0.389) | $0.078 | $0.428 |
knicksman wrote: I know it doesn't feel like there isn't any...but...for fun.
The company started to onboard patients in October. Onboarding accelerated in November. iDocsWeb patients will be onboarded in December. By the time we are midway through Q2, the company will have onboarded ~10k patients @ $50 per month. That means the company will have onboarded 10k patients in about 6 months. Onboarding was never expected to be linear...so lets assume the company onboards another ~20k in the next 8 months. By the end of C21, we could be exiting the year with run-rate revenues of $20 million at 80% gross profit.
They would be able to double that again next year.
Again....bull case...